FDA, Health Canada simultaneously review mastitis drug

FDA and Health Canada conduct simultaneous review and approval of veterinary drug for use in food-producing animals.

The U.S. Food & Drug Administration, in cooperation with Health Canada, announced the simultaneous approval of Elanco Animal Health's Imrestor (pegbovigrastim injection), a new animal drug intended to reduce the incidence of clinical mastitis of dairy cows and replacement dairy heifers.

According to the agencies, this is the fourth animal drug approved under collaborative initiative with Canada but the first animal drug to be simultaneously reviewed and approved for use in food

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.


Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)


Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.


SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx


TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx


Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish